Skip to main content
. 2016 Aug 3;2(2):vew020. doi: 10.1093/ve/vew020

Table 3.

Compartmentalization analysis for HIV RNA between blood plasma and CSF supernatant.

PID TP Timea (days) RT
GAG
ENV
Compartmentalized?
FST [CI] P FST [CI] P FST [CI] P RT GAG ENV
24409 1 2 0.02 [−0.12:0.17] 0.129 −0.24 [−0.40:0.03] 1.00 0.11 [0.05:0.18] <0.01 No No Yes
24409 2 11 0.07 [−0.05:0.20] <0.01 −0.03 [−0.18:0.14] 1.00 0.20 [0.14:0.29] <0.01 No No Yes
24409 3 17 −0.44 [−1.17: −0.00] 1.00 −0.15 [−0.95:0.14] 1.00# 0.07 [−0.58:0.24] <0.01 No No No
24409 4 47 0.28 [0.10:0.40] <0.01 0.22 [0.07:0.43] <0.01 0.67 [0.58:0.78] <0.01 Yes Yes Yes
24409 5 83 NA NA NA NA 0.38 [0.19:0.57] <0.01 Yes
25839 Pre-ART −2181 0.32 [0.07:0.57] <0.01 0.18 [−0.10:0.71] <0.01 0.18 [0.04:0.46] <0.01§ Yes No No
25839 1 3.5 −0.09 [−0.61:0.26] 1.00# 0.47 [−0.96:0.77] <0.01 −0.13 [−0.60:0.15] 1.00 No No No
25839 2 10.5 0.08 [−0.05:0.24] <0.01§ −0.10 [−0.30:0.69] 0.498 0.07 [−0.04:0.34] <0.01 No No No
58704 1 3.5 NA NA 0.87 [0.63:0.95] <0.01 0.18 [0.00:0.44] <0.01 Yes Yes
58704 2 10.5 0.17 [0.10:0.30] <0.01 0.50 [0.13:0.67] <0.01 0.02 [−0.02:0.09] <0.01# Yes Yes No
58704 3 25.5 −0.50 [−1.67: −0.07] 1.00 0.23 [−0.12:0.45] <0.01# 0.23 [0.10:0.42] <0.01 No No Yes
58704 4 31.5 NA NA 0.32 [−0.02:0.67] <0.01 0.10 [−0.51:0.46] <0.01# No No No
NM487 1 3.5 0.21 [0.15:0.30] <0.01 0.24 [0.03:0.41] <0.01 0.62 [0.24:0.86] <0.01 Yes Yes Yes
NM487 2 14.5 0.43 [0.28:0.61] <0.01 0.60 [0.42:0.81] <0.01 0.42 [0.30:0.61] <0.01 Yes Yes Yes
58786 1 9 0.05 [−0.56:0.72] 0.050 0.01 [−0.57:0.60] <0.01§# 0.36 [0.14:0.75] <0.01 No No Yes
58786 2 23 0.03 [−0.27:0.45] <0.01# −0.01 [−0.37:0.43] 1.00# 0.08 [0.04:0.20] <0.01§ No No No
24232 1 18 0.45 [0.23:0.65] <0.01 0.36 [0.01:0.73] <0.01§ 0.41 [0.26:0.62] <0.01 Yes No Yes
24232 2 375 0.65 [0.41:0.75] <0.01 0.07 [−0.16:0.23] <0.01# −0.20 [−0.76:0.12] 1.00 Yes No No
24273 1 11 0.21 [0.06:0.36] <0.01 0.22 [0.06:0.37] <0.01 0.30 [0.16:0.51] <0.01 Yes Yes Yes
24273 2 383 0.21 [0.01:0.35] <0.01 0.14 [−0.02:0.32] <0.01 0.61 [0.46:0.71] <0.01 Yes No Yes
23350 1 19 0.04 [−0.06:0.33] <0.01 −0.24 [−0.47:0.36] 1.00 −0.01 [−0.22:0.45] 0.703 No No No
23350 2 557 0.01 [−0.01:0.06] <0.01§# 0.06 [−0.02:0.19] <0.01§ −0.01 [−0.60:0.06] 1.00 No No No
26618 1 150 0.13 [−0.04:0.29] <0.01 0.15 [−0.06:0.54] <0.01 0.15 [0.03:0.29] <0.01 No No Yes
26618 2 514 −0.04 [−0.29:0.16] 1.00 0.26 [−0.09:0.48] <0.01 0.04 [−0.04:0.12] <0.01 No No No
34535 Pre-ART −732 0.12 [−0.12:0.47] <0.01 0.82 [0.18:0.94] <0.01 0.19 [0.03:0.43] <0.01 No Yes Yes
34535 1 37.5 0.09 [−0.22:0.42] <0.01 0.07 [−0.13:0.23] <0.01§ 0.33 [0.08:0.46] <0.01 No No Yes
58213 1 175 0.14 [−0.02:0.30] <0.01 0.11 [−0.09:0.37] <0.01 0.40 [0.24:0.60] <0.01 No No Yes
58213 2 319 0.03 [−0.92:0.35] <0.01# 0.32 [−0.28:0.65] <0.01 0.59 [0.46:0.69] <0.01 No No Yes
26742 1 104 −0.60 [−0.83: −0.30] 1.00 0.01 [−0.10:0.18] 0.079 0.00 [−0.04:0.07] 0.337 No No No
26742 2 159 0.39 [0.12:0.62] <0.01 0.01 [−0.09:0.15] 0.050 0.01 [−0.00:0.07] <0.01§# Yes No No
26919 Pre-ART −21 0.25 [0.10:0.42] <0.01 0.13 [0.02:0.32] <0.01 0.20 [0.11:0.34] <0.01 Yes Yes Yes
26919 1 7 NA NA 0.18 [−0.02:0.34] <0.01 0.08 [−0.02:0.18] <0.01 No No
26919 2 16 0.06 [0.02:0.14] <0.01 0.30 [−0.07:0.64] <0.01 0.08 [0.01:0.14] <0.01 Yes No Yes
26919 3 99 −0.01 [−0.06:0.08] 0.743 0.13 [0.01:0.26] <0.01 0.19 [0.11:0.29] <0.01 No Yes Yes
CA149 1 137 0.08 [−0.28:0.28] <0.01# −0.06 [−0.83:0.37] 1.00 −0.45 [−0.65: −0.24] 1.00 No No No
CA149 2 503 0.60 [0.48:0.72] <0.01 0.68 [0.50:0.83] <0.01 0.71 [0.62:0.79] <0.01 Yes Yes Yes

TP, time point collected sequentially after ART interruption, pre-ART time points were collected before starting antiretroviral therapy; ENV, envelope; RT, reverse transcriptase; BP, blood plasma; CSF, cerebrospinal fluid; confidence intervals are estimated by computing FST values for 100 replicates drawn by sampling alignment sites with replacement and adding noise to haplotype frequencies [see text]; P values <0.01 are derived from 100 bootstrap replicates, when 0/100 replicates had FST values equal to or greater than the estimate obtained from the data. Compartmentalization is called when four tests indicate compartmentalization [see text]

#Indicates tests which become significant (or not significant) if copy numbers are ignored during FST calculations.

§Indicates tests which become insignificant under the phylogeny-based SlatkinMaddison test [see text].

*time in days elapsed from viral rebound to sampling in CSF.